Renovorxincis A Clinical Stage Biopharmaceutical Company Based In Los Altoscaliforniafounded In 2009The Company Is Focused On Developing Innovative Targeted Oncology Therapies To Improve Treatment Outcomes For Cancer Patientsrenovorx Specializes In Targeted Delivery Systemsutilizing Technologies Like Trans Arterial Micro Perfusiontampand Devices Such As Renovocath For Precise Delivery Of Therapeutic Agents To Specific Tumor Sites The Lead Product Candidaterenovogemis An Oncology Drug Device Combination Currently In Phase Iii Clinical Trials For Locally Advanced Pancreatic Cancerrenovorx Also Collaborates With Imugene Limited To Explore Oncolytic Virus Therapy For Challenging Tumorshighlighting Its Commitment To Addressing Significant Unmet Medical Needs In Oncologywith A Focus On Precision Medicinerenovorx Aims To Enhance Treatment Efficacy And Is Positioned As A Key Player In The Medical Devices And Targeted Therapies Market
